{"id":8554,"date":"2021-06-21T14:38:00","date_gmt":"2021-06-21T14:38:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=8554"},"modified":"2024-05-02T09:59:24","modified_gmt":"2024-05-02T07:59:24","slug":"pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2\/","title":{"rendered":"Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/link.springer.com\/article\/10.1007\/s12328-021-01460-0#auth-Munenori-Kawai\">Munenori Kawai<\/a>,&nbsp;<a href=\"https:\/\/link.springer.com\/article\/10.1007\/s12328-021-01460-0#auth-Chiharu-Kawanami\">Chiharu Kawanami<\/a>,&nbsp;<a href=\"https:\/\/link.springer.com\/article\/10.1007\/s12328-021-01460-0#auth-Akihisa-Fukuda\">Akihisa Fukuda<\/a>&nbsp;&amp;&nbsp;<a href=\"https:\/\/link.springer.com\/article\/10.1007\/s12328-021-01460-0#auth-Hiroshi-Seno\">Hiroshi Seno<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Clin J Gastroenterol. 2021 Oct;14(5):1561-1566.&nbsp;doi: 10.1007\/s12328-021-01460-0.&nbsp;Epub 2021 Jun 8.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>An 18-year-old woman was admitted to our hospital with fever, diarrhea and painful skin ulcers in both pretibial areas starting 19 days earlier. The skin lesions appeared deep necrotic ulcers with violaceous undermined borders. She had been diagnosed as ulcerative colitis and primary sclerosing cholangitis (PSC) 6 and 5 years before, respectively, and had stopped having regular check-up and refused medication for years. Her clinical history and skin lesions led us to suspect of pyoderma gangrenosum (PG). The skin biopsy showed aseptic abscess formation with neutrophils infiltration in the dermis without bacteria. Thus, she was diagnosed with PG. 1 mg\/kg\/day of prednisolone was administered and ten sessions of granulocyte and monocyte adsorption apheresis (GMA) were started. Magnetic resonance cholangiography showed multifocal bile duct strictures due to PSC. Total colonoscopy revealed ulcerative pancolitis with spared normal mucosa in the rectum. After the treatments, her symptoms and the skin lesion improved dramatically. She was discharged on the 45th day with 25 mg\/day of prednisolone. In conclusion, this is the first reported case of PG with PSC-associated colitis that showed dramatic response to the concomitant GMA therapy with corticosteroids. Together with previous reports, concomitant GMA therapy with corticosteroids may be an effective treatment for PG.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34101129\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34101129\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Munenori Kawai,&nbsp;Chiharu Kawanami,&nbsp;Akihisa Fukuda&nbsp;&amp;&nbsp;Hiroshi Seno Clin J Gastroenterol. 2021 Oct;14(5):1561-1566.&nbsp;doi: 10.1007\/s12328-021-01460-0.&nbsp;Epub 2021 Jun 8. An 18-year-old woman was admitted to our hospital with fever, diarrhea and painful skin ulcers in both pretibial areas starting 19 days earlier. The skin lesions appeared deep necrotic ulcers with violaceous undermined borders. She had been diagnosed as ulcerative colitis [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[307,526,424,366,333,115,527,306],"class_list":["post-8554","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-dermatology","scientific_tags-eim","scientific_tags-gma","scientific_tags-neutrophil-infiltration","scientific_tags-primary-sclerosing-cholangitis","scientific_tags-pyoderma-gangrenosum","scientific_tags-steroid","scientific_tags-ulcerative-colitis"],"acf":{"sc_authors":"<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34101129\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34101129\/<\/a>"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Munenori Kawai,&nbsp;Chiharu Kawanami,&nbsp;Akihisa Fukuda&nbsp;&amp;&nbsp;Hiroshi Seno Clin J Gastroenterol. 2021 Oct;14(5):1561-1566.&nbsp;doi: 10.1007\/s12328-021-01460-0.&nbsp;Epub 2021 Jun 8. An 18-year-old woman was admitted to our hospital with fever, diarrhea and painful skin ulcers in both pretibial areas starting 19 days earlier. The skin lesions appeared deep necrotic ulcers with violaceous undermined borders. She had been diagnosed as ulcerative colitis [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T07:59:24+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2\/\",\"name\":\"Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2021-06-21T14:38:00+00:00\",\"dateModified\":\"2024-05-02T07:59:24+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids - Adacyte","og_description":"Munenori Kawai,&nbsp;Chiharu Kawanami,&nbsp;Akihisa Fukuda&nbsp;&amp;&nbsp;Hiroshi Seno Clin J Gastroenterol. 2021 Oct;14(5):1561-1566.&nbsp;doi: 10.1007\/s12328-021-01460-0.&nbsp;Epub 2021 Jun 8. An 18-year-old woman was admitted to our hospital with fever, diarrhea and painful skin ulcers in both pretibial areas starting 19 days earlier. The skin lesions appeared deep necrotic ulcers with violaceous undermined borders. She had been diagnosed as ulcerative colitis [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T07:59:24+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2\/","name":"Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2021-06-21T14:38:00+00:00","dateModified":"2024-05-02T07:59:24+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/pyoderma-gangrenosum-with-primary-sclerosing-cholangitis-associated-colitis-successfully-treated-with-concomitant-granulocyte-and-monocyte-adsorption-apheresis-with-corticosteroids-2\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/8554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=8554"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=8554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}